Global Kidney Cancer Drugs Market Size, Status and Forecast 2025

March 2018 | 103 pages | ID: G4037A7A3E2QEN
QYResearch

Abstracts

This report studies the global Kidney Cancer Drugs market, analyzes and researches the Kidney Cancer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Pfizer
• Abbott Laboratories
• Glaxosmithkline PLC
• Novartis AG
• Bayer AG
• Active Biotech
• Amgen
• Cipla Limited
• F. Hoffmann-La Roche
• Genentech
• Prometheus Laboratories
• Exelixis
• Onyx Pharmaceuticals
• Aveo Pharmaceuticals
• Immatics Biotechnologies

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• Nexavar (Sorafenib)
• Sutent (Sunitinib)
• Afinitor (Everolimus)
• Votrient (Pazopanib)
• Avastin (Bevacizumab)
• Inlyta (Axitinib)
• Torisel (Temsirolimus)
• Proleukin (Aldesleukin)
• Other

Market segment by Application, Kidney Cancer Drugs can be split into

• Hospitals
• Clinics
• Research Center
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Kidney Cancer Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF KIDNEY CANCER DRUGS

1.1 Kidney Cancer Drugs Market Overview
  1.1.1 Kidney Cancer Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Kidney Cancer Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Kidney Cancer Drugs Market by Type
  1.3.1 Nexavar (Sorafenib)
  1.3.2 Sutent (Sunitinib)
  1.3.3 Afinitor (Everolimus)
  1.3.4 Votrient (Pazopanib)
  1.3.5 Avastin (Bevacizumab)
  1.3.6 Inlyta (Axitinib)
  1.3.7 Torisel (Temsirolimus)
  1.3.8 Proleukin (Aldesleukin)
  1.3.9 Other
1.4 Kidney Cancer Drugs Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Research Center
  1.4.4 Other

2 GLOBAL KIDNEY CANCER DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Kidney Cancer Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Pfizer
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Abbott Laboratories
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Glaxosmithkline PLC
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 Novartis AG
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Bayer AG
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Active Biotech
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Amgen
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Cipla Limited
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 F. Hoffmann-La Roche
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Genentech
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Kidney Cancer Drugs Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Prometheus Laboratories
3.12 Exelixis
3.13 Onyx Pharmaceuticals
3.14 Aveo Pharmaceuticals
3.15 Immatics Biotechnologies

4 GLOBAL KIDNEY CANCER DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Kidney Cancer Drugs Market Size by Type (2013-2018)
4.2 Global Kidney Cancer Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Kidney Cancer Drugs in Future
4.4 Top Consumer/End Users of Kidney Cancer Drugs

5 UNITED STATES KIDNEY CANCER DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Kidney Cancer Drugs Market Size (2013-2018)
5.2 United States Kidney Cancer Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Kidney Cancer Drugs Market Size by Application (2013-2018)

6 EU KIDNEY CANCER DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Kidney Cancer Drugs Market Size (2013-2018)
6.2 EU Kidney Cancer Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Kidney Cancer Drugs Market Size by Application (2013-2018)

7 JAPAN KIDNEY CANCER DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Kidney Cancer Drugs Market Size (2013-2018)
7.2 Japan Kidney Cancer Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Kidney Cancer Drugs Market Size by Application (2013-2018)

8 CHINA KIDNEY CANCER DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Kidney Cancer Drugs Market Size (2013-2018)
8.2 China Kidney Cancer Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Kidney Cancer Drugs Market Size by Application (2013-2018)

9 INDIA KIDNEY CANCER DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Kidney Cancer Drugs Market Size (2013-2018)
9.2 India Kidney Cancer Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Kidney Cancer Drugs Market Size by Application (2013-2018)

10 SOUTHEAST ASIA KIDNEY CANCER DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Kidney Cancer Drugs Market Size (2013-2018)
10.2 Southeast Asia Kidney Cancer Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Kidney Cancer Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Kidney Cancer Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Kidney Cancer Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Kidney Cancer Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Kidney Cancer Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Kidney Cancer Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Kidney Cancer Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Kidney Cancer Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Kidney Cancer Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Kidney Cancer Drugs Market Size by Application (2018-2025)

12 KIDNEY CANCER DRUGS MARKET DYNAMICS

12.1 Kidney Cancer Drugs Market Opportunities
12.2 Kidney Cancer Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Kidney Cancer Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Kidney Cancer Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Kidney Cancer Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Kidney Cancer Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Kidney Cancer Drugs Market Share by Regions (2013-2018)
Figure United States Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Kidney Cancer Drugs Revenue Market Share by Type in 2017
Figure Nexavar (Sorafenib) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Sutent (Sunitinib) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Afinitor (Everolimus) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Votrient (Pazopanib) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Avastin (Bevacizumab) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Inlyta (Axitinib) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Torisel (Temsirolimus) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Proleukin (Aldesleukin) Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Kidney Cancer Drugs Market Share by Application in 2017
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Research Center (2013-2018)
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure Kidney Cancer Drugs Market Size Share by Players in 2013
Figure Kidney Cancer Drugs Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Abbott Laboratories Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Abbott Laboratories (2013-2018)
Figure Abbott Laboratories Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Glaxosmithkline PLC Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Glaxosmithkline PLC (2013-2018)
Figure Glaxosmithkline PLC Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Novartis AG (2013-2018)
Figure Novartis AG Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Bayer AG Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Bayer AG (2013-2018)
Figure Bayer AG Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Active Biotech Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Active Biotech (2013-2018)
Figure Active Biotech Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Amgen Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Amgen (2013-2018)
Figure Amgen Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Cipla Limited Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Cipla Limited (2013-2018)
Figure Cipla Limited Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Genentech Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Genentech (2013-2018)
Figure Genentech Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Prometheus Laboratories Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Prometheus Laboratories (2013-2018)
Figure Prometheus Laboratories Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Exelixis Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Exelixis (2013-2018)
Figure Exelixis Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Onyx Pharmaceuticals Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Onyx Pharmaceuticals (2013-2018)
Figure Onyx Pharmaceuticals Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Aveo Pharmaceuticals Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Aveo Pharmaceuticals (2013-2018)
Figure Aveo Pharmaceuticals Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Immatics Biotechnologies Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Immatics Biotechnologies (2013-2018)
Figure Immatics Biotechnologies Kidney Cancer Drugs Business Revenue Market Share (2013-2018)
Table Global Kidney Cancer Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Kidney Cancer Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Kidney Cancer Drugs Market Share by Product in 2017
Table Global Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure Global Kidney Cancer Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Kidney Cancer Drugs
Figure United States Kidney Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Kidney Cancer Drugs Market Size Share by Players in 2013
Figure United States Kidney Cancer Drugs Market Size Share by Players in 2017
Table United States Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure United States Kidney Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Kidney Cancer Drugs Market Size Share by Application in 2017
Figure EU Kidney Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Kidney Cancer Drugs Market Size Share by Players in 2013
Figure EU Kidney Cancer Drugs Market Size Share by Players in 2017
Table EU Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure EU Kidney Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Kidney Cancer Drugs Market Size Share by Application in 2017
Figure Japan Kidney Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Kidney Cancer Drugs Market Size Share by Players in 2013
Figure Japan Kidney Cancer Drugs Market Size Share by Players in 2017
Table Japan Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure Japan Kidney Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Kidney Cancer Drugs Market Size Share by Application in 2017
Figure China Kidney Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Kidney Cancer Drugs Market Size Share by Players in 2013
Figure China Kidney Cancer Drugs Market Size Share by Players in 2017
Table China Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure China Kidney Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Kidney Cancer Drugs Market Size Share by Application in 2017
Figure India Kidney Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Kidney Cancer Drugs Market Size Share by Players in 2013
Figure India Kidney Cancer Drugs Market Size Share by Players in 2017
Table India Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure India Kidney Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Kidney Cancer Drugs Market Size Share by Application in 2017
Figure Southeast Asia Kidney Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Kidney Cancer Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Kidney Cancer Drugs Market Size Share by Players in 2013
Figure Southeast Asia Kidney Cancer Drugs Market Size Share by Players in 2017
Table Southeast Asia Kidney Cancer Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Kidney Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Kidney Cancer Drugs Market Size Share by Application in 2017
Figure Global Kidney Cancer Drugs Market Size and Growth Rate (2018-2025)
Table Global Kidney Cancer Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Kidney Cancer Drugs Market Size Share (2018-2025)
Figure Global Kidney Cancer Drugs Market Size Share by Regions in 2025
Figure United States Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Kidney Cancer Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2018
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2025
Table Global Kidney Cancer Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2018
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2025